ANTI-TNF THERAPY AND THE RISK OF MALIGNANCIES AND INFECTIONS IN INFLAMMATORY RHEUMATIC DISEASES - OUR EXPERIENCE

Pap, Mislav; Sapina, Ivana; Laktašić-Žerjavić, Nadica; Žagar, Iva; KovačDurmiš, Kristina; Kalebota, Nataša; Kovačević, Petra; LjudevitCaktaš, Ivan; Dekleva, Vanja; Birkić, Duje; KolarMitrović, Helena; Perić, Porin

Psychiatria Danubina, Vol. 33 No. suppl 2, 2021.

Izlaganje sa skupa

ANTI-TNF THERAPY AND THE RISK OF MALIGNANCIES AND INFECTIONS IN INFLAMMATORY RHEUMATIC DISEASES - OUR EXPERIENCE

Mislav Pap
Ivana Sapina
Nadica Laktašić-Žerjavić
Iva Žagar
Kristina KovačDurmiš
Nataša Kalebota
Petra Kovačević
Ivan LjudevitCaktaš
Vanja Dekleva
Duje Birkić
Helena KolarMitrović
Porin Perić

Puni tekst: engleski pdf 84 Kb

str. 209-209

preuzimanja: 147

citiraj

APA 6th Edition

Pap, M., Sapina, I., Laktašić-Žerjavić, N., Žagar, I., KovačDurmiš, K., Kalebota, N., ... Perić, P. (2021). ANTI-TNF THERAPY AND THE RISK OF MALIGNANCIES AND INFECTIONS IN INFLAMMATORY RHEUMATIC DISEASES - OUR EXPERIENCE. Psychiatria Danubina, 33 (suppl 2), 209-209. Preuzeto s https://hrcak.srce.hr/index.php/270107

MLA 8th Edition

Pap, Mislav, et al. "ANTI-TNF THERAPY AND THE RISK OF MALIGNANCIES AND INFECTIONS IN INFLAMMATORY RHEUMATIC DISEASES - OUR EXPERIENCE." Psychiatria Danubina, vol. 33, br. suppl 2, 2021, str. 209-209. https://hrcak.srce.hr/index.php/270107. Citirano 01.05.2024.

Chicago 17th Edition

Pap, Mislav, Ivana Sapina, Nadica Laktašić-Žerjavić, Iva Žagar, Kristina KovačDurmiš, Nataša Kalebota, Petra Kovačević, et al. "ANTI-TNF THERAPY AND THE RISK OF MALIGNANCIES AND INFECTIONS IN INFLAMMATORY RHEUMATIC DISEASES - OUR EXPERIENCE." Psychiatria Danubina 33, br. suppl 2 (2021): 209-209. https://hrcak.srce.hr/index.php/270107

Harvard

Pap, M., et al. (2021). 'ANTI-TNF THERAPY AND THE RISK OF MALIGNANCIES AND INFECTIONS IN INFLAMMATORY RHEUMATIC DISEASES - OUR EXPERIENCE', Psychiatria Danubina, 33(suppl 2), str. 209-209. Preuzeto s: https://hrcak.srce.hr/index.php/270107 (Datum pristupa: 01.05.2024.)

Vancouver

Pap M, Sapina I, Laktašić-Žerjavić N, Žagar I, KovačDurmiš K, Kalebota N i sur. ANTI-TNF THERAPY AND THE RISK OF MALIGNANCIES AND INFECTIONS IN INFLAMMATORY RHEUMATIC DISEASES - OUR EXPERIENCE. Psychiatria Danubina [Internet]. 2021 [pristupljeno 01.05.2024.];33(suppl 2):209-209. Dostupno na: https://hrcak.srce.hr/index.php/270107

IEEE

M. Pap, et al., "ANTI-TNF THERAPY AND THE RISK OF MALIGNANCIES AND INFECTIONS IN INFLAMMATORY RHEUMATIC DISEASES - OUR EXPERIENCE", Psychiatria Danubina, vol.33, br. suppl 2, str. 209-209, 2021. [Online]. Dostupno na: https://hrcak.srce.hr/index.php/270107. [Citirano: 01.05.2024.]

Sažetak

Ključne riječi

Hrčak ID:

270107

URI

https://hrcak.srce.hr/270107

Datum izdavanja:

21.5.2021.

Posjeta: 246 *

Prijava i registracija

Psychiatria Danubina, Vol. 33 No. suppl 2, 2021.

Sažetak

Ključne riječi

Hrčak ID:

URI

Datum izdavanja: